Acknowledgment: The authors thank all participating hospitals, especially all cardiac residents, nurses, secretaries, research and development departments, and local laboratories (Diagnostisch Laboratorium Saltro Utrecht, Atalmedial, MDC Amstelland, Trombosedienst Gelderse vallei Ede, Diagnostiek voor U, and the laboratory of Atrium Medical Center). They also thank their monitor, Gerda Kuiper; the Data Safety and Monitoring Board (Arend Mosterd, Kit Roes, Gert-Jan de Borst, Carla Bruijnzeel-Koomen, and Caroline van Baal); the data managers (Jildou Zwerver, Susan van Hemert, and Joost Schotsman); and the trial nurses (Lydeke Zwart, Carla Tims-Polderman, Els Kooiman, Boudewijn Uppelschoten, and Mieke de Haas) for their extensive help during data collection. Finally, the authors thank the members of their outcome committee for their precise adjudication, especially the extra members of the adjudication consensus committee (Adriaan van Kraaijeveld and Jeroen Smits).
Grant Support: A research grant was obtained from the Netherlands Organisation for Health Research and Development (ZorgOnderzoek Nederland en Medische wetenschappen [ZonMw]) (grant project 171202015) as part of the Effectiveness Program (Doelmatigheidsprogramma ZonMw).
Disclosures: Prof. Hoes reports that he chairs a large research and teaching institute within University Medical Center Utrecht that performs investigator- and industry-driven research projects with numerous pharmaceutical and diagnostic companies. In addition, some staff members receive unrestricted grants for research projects from a number of companies. It is the explicit policy of the institute to work with several companies and not focus on 1 or 2 industrial partners. Prof. Hoes receives no personal payment from any industrial partner. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at
www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M16-1600.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that she has no financial relationships or interests to disclose. Darren B. Taichman, MD, PhD, Executive Deputy Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Pfizer and Johnson & Johnson.
Corresponding Author: Judith M. Poldervaart, MD, PhD, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Straat 6.101, PO Box 85500, 3508 AB Utrecht, the Netherlands; e-mail,
[email protected].
Current Author Addresses: Drs. Poldervaart, Reitsma, and Koffijberg; Ms. Lagerweij; and Prof. Hoes: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Straat 6.101, PO Box 85500, 3508 AB Utrecht, the Netherlands.
Dr. Backus: Department of Emergency Medicine, Haaglanden Medical Center, Lijnbaan 32, 2512 VA The Hague, the Netherlands.
Dr. Veldkamp: Department of Cardiology, Haaglanden Medical Center, Lijnbaan 32, 2512 VA The Hague, the Netherlands.
Drs. ten Haaf and Appelman: Department of Cardiology, Vu University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.
Dr. Mannaerts: Department of Cardiology, Amstelland Hospital, Amstelveen, the Netherlands.
Drs. van Dantzig, van den Heuvel, and el Farissi: Department of Cardiology, Catharina Hospital, Michelangelolaan 9, 5623 AZ Eindhoven, the Netherlands.
Dr. Rensing: Department of Cardiology, St. Antonius Hospital, Koekoekslaan 1, 3435 CM Nieuwegein, the Netherlands.
Drs. Ernst and Dekker: Department of Cardiology, Zuyderland Hospital, Heerlen, the Netherlands.
Drs. den Hartog and Oosterhof: Department of Cardiology, Gelderse Vallei Hospital, Willy Brandtlaan 10, 6716 RP Ede, the Netherlands.
Dr. Buijs: Department of Cardiology, Tergooi Hospital, Rijksstraatweg 1, 1261 AN Hilversum, the Netherlands.
Dr. van Hessen: Department of Cardiology, Groene Hart Hospital, Bleuland Weg 10, 2803 HH Gouda, the Netherlands.
Dr. Landman: Department of Cardiology, Meander Medical Center, Maatweg 3, 3813 TZ Amersfoort, the Netherlands.
Dr. van Kimmenade: Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, the Netherlands.
Dr. Cozijnsen: Department of Cardiology, Gelre Hospital, PO Box 9014, 7300 DS Apeldoorn, the Netherlands.
Drs. Bucx and van Ofwegen-Hanekamp: Department of Cardiology, Diakonessenhuis Utrecht, Bosboomstraat 1, 3582 KE Utrecht, the Netherlands.
Dr. Cramer and Prof. Doevendans: Department of Cardiology, University Medical Center Utrecht, Heidelberglaan 100, 3508 GA Utrecht, the Netherlands.
Dr. Six: Department of Cardiology, Zuwe Hofpoort Hospital, Sterrenburg 1, 3447 GN Woerden, the Netherlands.
Author Contributions: Conception and design: J.M. Poldervaart, J.B. Reitsma, A.J. Six, P.A. Doevendans, A.W. Hoes.
Analysis and interpretation of the data: J.M. Poldervaart, J.B. Reitsma, H. Koffijberg, G.R. Lagerweij, E.M. Buijs, A.J. Six.
Drafting of the article: J.M. Poldervaart, J.B. Reitsma, A.J. Six, A.W. Hoes.
Critical revision of the article for important intellectual content: J.M. Poldervaart, J.B. Reitsma, B.E. Backus, H. Koffijberg, R.F. Veldkamp, M.E. ten Haaf, Y. Appelman, E.M. Buijs, A.J. Six, P.A. Doevendans, A.W. Hoes.
Final approval of the article: J.M. Poldervaart, J.B. Reitsma, B.E. Backus, H. Koffijberg, R.F. Veldkamp, M.E. ten Haaf, Y. Appelman, H.F.J. Mannaerts, J.M. van Dantzig, M. van den Heuvel, M. el Farissi, B.J.W.M. Rensing, N.M.S.K.J. Ernst, I.M.C. Dekker, F.R. den Hartog, T. Oosterhof, G.R. Lagerweij, E.M. Buijs, M.W.J. van Hessen, M.A.J. Landman, R.R.J. van Kimmenade, L. Cozijnsen, J.J.J. Bucx, C.E.E. van Ofwegen-Hanekamp, M.J. Cramer, A.J. Six, P.A. Doevendans, A.W. Hoes.
Provision of study materials or patients: J.M. Poldervaart, R.F. Veldkamp, M.E. ten Haaf, Y. Appelman, J.M. van Dantzig, N.M.S.K.J. Ernst, F.R. den Hartog, T. Oosterhof, J.J.J. Bucx, C.E.E. van Ofwegen-Hanekamp, A.J. Six.
Statistical expertise: J.M. Poldervaart, J.B. Reitsma, H. Koffijberg, G.R. Lagerweij.
Obtaining of funding: B.E. Backus, A.J. Six.
Administrative, technical, or logistic support: J.M. Poldervaart, B.E. Backus, R.F. Veldkamp, M.E. ten Haaf, J.M. van Dantzig, M. van den Heuvel, M. el Farissi, I.M.C. Dekker, E.M. Buijs, R.R.J. van Kimmenade, L. Cozijnsen, J.J.J. Bucx, C.E.E. van Ofwegen-Hanekamp, A.J. Six.
Collection and assembly of data: J.M. Poldervaart, R.F. Veldkamp, M.E. ten Haaf, H.F.J. Mannaerts, J.M. van Dantzig, M. van den Heuvel, M. el Farissi, B.J.W.M. Rensing, N.M.S.K.J. Ernst, I.M.C. Dekker, T. Oosterhof, E.M. Buijs, M.A.J. Landman, M.J. Cramer, A.J. Six.
This article was published at
Annals.org on 25 April 2017.
Author's Response
In the dataset of the HEART-Impact trial 136 of the 1766 patients (7.7%) had a HEART score of 0 (n=30) or 1 (n=106); none of these 136 patients had a positive troponin measurement, suggesting a small efficiency gain of these 8% of patients who possibly may be discharged very early from the emergency department, without a troponin measurement. Taking a two-step approach by only performing troponin testing in those that have a maximum total score of 1 on the other items (HEAR) of the HEART score might be more cost-effective, but this algorithm not assessed in our study. Our aim was to determine the value of the HEART score in daily practice.
We wish to stress once again the fact that the HEART score is a decision tool, and not a strict rule to adhere to, in all chest pain patients. For example, in patients with a very clear low probability, the physician may decide not to use the HEART score at all. What is crucial here is the suspicion of the physician: when one suspects a patient of a possible acute coronary syndrome, he or she can decide to calculate the HEART score. More importantly, in every patient with suspicion of acute coronary syndrome, the physician will want to perform a troponin measurement for understandable safety reasons, since this measurement is so sensitive for detecting myocardial damage.
Overall, the diagnostic dilemma of acute coronary syndrome is one of the balance between efficiency and safety, which is a discussion also to be held in a broader societal context. What risk do we find acceptable in chest pain patients, when also incorporating the risk of overtreatment?
The CARE score (taking a 2 step approach) the authors are currently testing seems very interesting and we are looking forward to the publication of their findings.
Comments on Effect of Using the HEART Score in Patients With Chest Pain in the Emergency Department: A Stepped-Wedge Cluster Randomized Trial
1. Chaou C-H, Chen H-H, Chang S-H, et al. Predicting Length of Stay among Patients Discharged from the Emergency Department—Using an Accelerated Failure Time Model. PLOS ONE. 2017;12(1):e0165756. doi:10.1371/journal.pone.0165756.
2. Sox H, Stern S, Owens D, et al.; Institute of Medicine (US) Council on Health Care Technology. Assessment of Diagnostic Technology in Health Care: Rationale, Methods, Problems, and Directions: Monograph of the Council on Health Care Technology. Washington (DC): National Academies Press (US); 1989. 2, p 23-54, The Use of Diagnostic Tests: A Probabilistic Approach.
3. Zhelev Z, Hyde C, Youngman E, et al. Diagnostic accuracy of single baseline measurement of Elecsys Troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysis. BMJ. 2015;350:h15. doi:10.1136/bmj.h15.
4. Singh B, Mommer SK, Erwin PJ, Mascarenhas SS, Parsaik AK. Pulmonary embolism rule-out criteria (PERC) in pulmonary embolism--revisited: a systematic review and meta-analysis. Emerg Med J EMJ. 2013;30(9):701-706. doi:10.1136/emermed-2012-201730.